30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in Chinese medicinal preparation Fuzilizhong pills using UPLC with quadrupole time-of-flight MS.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Fuzilizhong Pills (FZLZ), a modified form of a famous traditional Chinese medicine (TCM) Lizhong Wan in Treatise on Febrile Diseases and consisting of Panax ginseng C.A.Mey. (Ren Shen), Aconitum carmichaelii Debx. (Fu Zi, Zhi), Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L. (Gan Cao), Atractylodes macrocephala Koidz. (Bai Zhu) and Zingiber offcinale Rosc. (Gan Jiang), show strong clinical therapeutic effects for dyspnea and pulmonary oedema. However, the bioactive compounds are still unclear. In this study, FZLZ was analysed using a rapid detection method to identify its anti-inflammatory and spasmolytic constituents.

          Related collections

          Author and article information

          Journal
          Phytochem Anal
          Phytochemical analysis : PCA
          Wiley-Blackwell
          1099-1565
          0958-0344
          October 12 2013
          : 25
          : 2
          Affiliations
          [1 ] Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), College of Pharmacy, Tianjin Medical University, 300070, Tianjin, China.
          Article
          10.1002/pca.2474
          24115085
          abcee915-917d-4a31-b534-e95055016a5e
          History

          Dual-bioactivity-integrated fingerprinting,Fuzilizhong pills,UPLC-QTOF/MS/MS,nuclear factor-κB inhibitors,β2 adrenergic receptor agonists

          Comments

          Comment on this article